These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 872096)
41. [Morphological and ultrastructural indicators of early cardiotoxicity in rats after the administration of rubidomycin and its derivatives]. Chibowski D; Siezieniewska Z; Kleinrok Z; Chmielewska B Patol Pol; 1984; 35(4):453-79. PubMed ID: 6535952 [No Abstract] [Full Text] [Related]
42. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit. Jaenke RS Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204 [TBL] [Abstract][Full Text] [Related]
43. QRS voltage change with adriamycin administration. Minow RA; Benjamin RS; Lee ET; Gottlieb JA Cancer Treat Rep; 1978 Jun; 62(6):931-4. PubMed ID: 667870 [TBL] [Abstract][Full Text] [Related]
44. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography. Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636 [No Abstract] [Full Text] [Related]
47. [Cardiotoxicity of doxorubicin in children]. Pilon JW; Naeff MS; Taminiau JA Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993 [No Abstract] [Full Text] [Related]
48. Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy. Fulkerson PK; Talley R; Kleinman D; Weaver SK; Leier CV; Balcerzak SP; Lewis RP Cancer Treat Rep; 1978 Jun; 62(6):881-6. PubMed ID: 667862 [No Abstract] [Full Text] [Related]
49. The cardiotoxicity of anticancer agents. Von Hoff DD; Rozencweig M; Piccart M Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608 [TBL] [Abstract][Full Text] [Related]
51. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine. Strauss M; Porras N Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542 [TBL] [Abstract][Full Text] [Related]
52. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
53. [Adriamycin induced chronic cardiotoxicity: a morphological ultrastructural study on ventricular myocardium and conducting system of rabbit heart (author's transl)]. Gandolfi A Ateneo Parmense Acta Biomed; 1976; 47(1):69-78. PubMed ID: 1016274 [TBL] [Abstract][Full Text] [Related]
54. Daunorubicin-induced cardiotoxicity. Morgan OS; Amin UF; Gibbs WN West Indian Med J; 1976 Mar; 25(1):58-63. PubMed ID: 1266211 [No Abstract] [Full Text] [Related]
55. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)]. Yamaguchi H; Toyota S; Takahara O; Ichimaru M Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049 [No Abstract] [Full Text] [Related]
56. Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration. Rahman A; More N; Schein PS Cancer Res; 1982 May; 42(5):1817-25. PubMed ID: 7066898 [TBL] [Abstract][Full Text] [Related]
57. Cardiotoxicity of adriamycin and related anthracyclines. Lenaz L; Page JA Cancer Treat Rev; 1976 Sep; 3(3):111-20. PubMed ID: 822941 [No Abstract] [Full Text] [Related]
59. Effect of saponin on mortality and histopathological changes in mice. Diwan FH; Abdel-Hassan IA; Mohammed ST East Mediterr Health J; 2000; 6(2-3):345-51. PubMed ID: 11556022 [TBL] [Abstract][Full Text] [Related]
60. [Contribution of electron microscopy to the study of anthracycline cardiotoxicity]. Anjo A; Levi F; Reynes M Bull Assoc Anat (Nancy); 1991 Jun; 75(229):7-9. PubMed ID: 1777720 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]